Weekly Buzz: FDA OKs Roche’s Lunsumio VELO; It’s No For Tolbrutinib; BioMarin, SNY Open Wallets

… (RTTNews) – In a holiday-shortened week, the biotech sector saw a wave of FDA … news, trends and education. Delivered Wednesdays. * Required …